Manufacturing facility
Anthea Pharma Private Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Unit-I, Plot No. 290 and 290 A, SY. No. 183 and 219, Phase III IDA, Pashamylaram Village. Patancheru Mandal, Sangareddy District., Sangareddy, Telengana 502307, India (IND)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3026048557 · DUNS 644169402
Drugs this plant is listed as making
6 distinct drugs across 16 products name this site in their FDA label.
- Bupivacaine Hydrochloridein shortageAnthea Pharma Private Limited
- LacosamideGlenmark Pharmaceuticals Inc., Usa
- Lidocaine Hydrochloridein shortageAnthea Pharma Private Limited
- OlanzapineGlenmark Pharmaceuticals Inc., Usa
- Ropivacaine Hydrochloridein shortageAnthea Pharma Private Limited
- Sodium Bicarbonatein shortageAnthea Pharma Private Limited
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.